Videos

Adam C. Welch, PharmD, MBA, FAPhA, evaluates the impact of yearly flu vaccinations on curtailing the spread of influenza among communities and populations.

With approximately 2 years of additional follow-up, lenvatinib plus pembrolizumab maintained robust effectiveness for nearly every patient.

Medical experts highlight the significant impact of pharmacists in multiple myeloma treatment pathways.

Experts discuss the role of proteasome inhibitors in combination therapy in the management of relapsed indolent multiple myeloma.

Dr Madison provides insights on the importance of and strategies for raising awareness to adult RSV vaccines.

Mary Bridgeman, PharmD, BCPS, BCGP, FASCP, Adam C. Welch, PharmD, MBA, FAPhA, and Christina Madison, PharmD, FCCP, AAHIVP, discuss the testing and treatment strategies for RSV.

A panel of experts discuss those most at risk for complications from the flu, and how flu vaccines may benefit them.

High-risk patient populations for pneumococcal pneumonia are discussed by Christina Madison, PharmD, FCCP, AAHIVP.

Key opinion leaders discuss factors leading to the development of novel pneumococcal vaccines.

Experts examine the yearly modifications in the formulations of flu vaccines and explore the variations in the adverse events experienced across different types of flu vaccines.

Expert Nikhil Palekar, MD, said that although the treatment is far from a cure, it is a vital first step toward other treatments for Alzheimer Disease.

Experts navigate the impact of proteasome inhibitors and anti-CD38 antibody therapies in the relapsed refractory multiple myeloma treatment landscape.

Experts highlight the use of 3- and 4-drug regimens for managing relapsed refractory multiple myeloma.

The panel explores RSV infection susceptibility and transmission.

Community health worker training can allow the technician to perform to the top of their abilities and improve access to the pharmacy’s public health services.

Key opinion leaders discuss risk factors for RSV and patient populations most susceptible to the disease.

COVID-19 is helping to shape current pharmacy practice, including increased vaccinations, access to care, and better interactions with patients.

An expert panel discusses the development of recombinant and cell-based vaccines and new types of influenza vaccines being explored.

Experts review how influenza vaccines have advanced in recent years and discuss misconceptions that people may have about standard-dose and high-dose flu vaccines.

Medical experts provide an overview of the signs and symptoms of pneumococcal infections.

Key opinion leaders provide insight on patient considerations when formulating an optimal treatment regimen for multiple myeloma.

Drs Haumschild, Anderson, and Hinojosa explore current MM treatment pathways.

Ryan Haumschild, PharmD, MS, MBA, leads a panel of medical experts in a discussion regarding adult RSV vaccination.

During the pandemic, many community pharmacists also gained the authority to provide routine vaccinations for child populations.

Liam Volk, MPharm, discussed the recent end of the FDA’s ban on gay and bisexual men donating blood, saying it’s a good step, although more must be done.

Medical experts discuss treatment options for indolent and aggressive relapse multiple myeloma.

Dr Haumschild opens the discussion with Larry Anderson, MD, PhD, and Gabe Hinojosa, PharmD, BCOP, regarding various states of relapse in multiple myeloma.

Health Mart is offering a new basic training program with ASHP/ACPE accreditation for pharmacy technicians, along with accredited and non-accredited training.

Christina Madison, PharmD, FCCP, AAHIVP, sat down with Sandra Leal, PharmD, MPH, FAPhA, CDCES, vice president of pharmacy practice innovation and advocacy at CVS Pharmacy, to discuss how pharmacists are diving into public health and expanding their roles.

Approximately 50% of patients with refractory or relapsed disease achieved complete response following treatment with the Janus kinase 1 (JAK1) inhibitor.